Angola vs South-East Asia (WHO region): Hepatitis B surface antigen (HBsAg) prevalence
Angola
3.1%
in 2024
South-East Asia (WHO region)
0.2%
in 2024
Angola rank
5th
South-East Asia (WHO region) rank
8th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Angola
- South-East Asia (WHO region)
How they compare
Angola currently reports 3.1% against 0.2% in South-East Asia (WHO region), a difference of 2.9%.
That makes Angola's figure about 15.5 times South-East Asia (WHO region)'s.
Across all 10 years both countries report, Angola has been ahead every year.
Angola ranks 5th and South-East Asia (WHO region) ranks 8th of 194 countries.
Angola has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 0.4% | 2.2% | Angola |
| 2020s | 3.0% | 0.3% | 2.8% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Angola or South-East Asia (WHO region)?
- Angola, at 3.1% against 0.2% in South-East Asia (WHO region) as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Angola and South-East Asia (WHO region)?
- 2.9%, with Angola ahead.
- How many years of comparable data are there for Angola and South-East Asia (WHO region)?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and South-East Asia (WHO region) rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Angola ranks 5th and South-East Asia (WHO region) ranks 8th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.